Alpa Laboratories appointed Radhika Biyani as an additional director in the independent, non-executive category, effective September 5, 2026. The appointment follows the completion of her Director Identification Number (DIN) allotment.

The Board of Directors approved the appointment during its meeting on August 13, 2026. It is subject to shareholder approval at the ensuing general meeting or via postal ballot, as required under Regulation 17 of the SEBI Listing Regulations.

Filling the vacancy

Biyani’s appointment fills the vacancy left by Jyoti Jain, whose tenure ended on July 21, 2026. The company noted an intervening period between the two dates due to the search, evaluation, and due diligence processes required under the Companies Act, 2013.

Alpa Laboratories stated it has strengthened internal tracking of director tenure timelines and DIN-related processes to prevent similar delays in the future.

Committee reconstitution

To maintain compliance with Regulations 18, 19, 20, and 21 of the SEBI Listing Regulations, the board reconstituted several key committees. Biyani joins the Nomination and Remuneration Committee alongside Sanket Baheti and Sunil Kumar Valecha. She also serves on the Stakeholders Relationship Committee with Sunil Kumar Valecha and Mahendra Singh Chawla.

Profile details

Biyani, aged 32, holds a Bachelor of Engineering degree. She brings over two years of work experience from Braintree and is currently employed in the private sector. She holds no shares in Alpa Laboratories and has no other directorships.

What the Numbers Show

The appointment highlights a focus on governance continuity. With Biyani holding zero shares in the company, her independence is structurally reinforced by a lack of equity stake, aligning with the regulatory requirement for independent directors to maintain objectivity free from financial interest in the firm's performance.

Alpa Laboratories has issued a clarification to the National Stock Exchange of India Limited and the Bombay Stock Exchange Limited regarding the date of its upcoming Board of Directors meeting. The company confirmed that the meeting is scheduled for Thursday, August 13, 2026, at 3:00 PM at its registered office in Indore. This correction addresses a typographical error in the subject line of the initial intimation uploaded to the exchange portal, which incorrectly cited August 14, 2026.

The clarification was communicated on August 11, 2026, by Shitil Shah, Director of Alpa Laboratories Limited (DIN: 07883973). The company emphasized that the date mentioned in the body of the intimation and the eXtensible Business Reporting Language (XBRL) file remained accurate as August 13. The error was isolated to the subject line text on the portal.

Meeting Details

The Board meeting will be held at the company's registered office located at 33/2, A.B. Road, Pigdamber-453446, District Indore, Madhya Pradesh. The proceedings are set to begin at 3:00 PM.

Regulatory Compliance

The notice was addressed to the Listing Departments of both the National Stock Exchange of India Limited and the Bombay Stock Exchange Limited. Alpa Laboratories expressed regret for any confusion caused by the discrepancy and requested understanding from the exchanges. The correction ensures alignment between the public intimation and the actual schedule of the corporate governance proceeding.